| Year |
Citation |
Score |
| 2021 |
Wang F, Zhu C, Cai S, Boudreau A, Kim SJ, Bissell M, Shao J. Ser Phosphorylation Inhibits Actin-Binding of Profilin-1 and Its Apoptosis-Sensitizing Activity. Frontiers in Cell and Developmental Biology. 9: 692269. PMID 34235154 DOI: 10.3389/fcell.2021.692269 |
0.485 |
|
| 2015 |
Diamond MI, Cai S, Boudreau A, Carey CJ, Lyle N, Pappu RV, Swamidass SJ, Bissell M, Piwnica-Worms H, Shao J. Subcellular localization and Ser-137 phosphorylation regulate tumor-suppressive activity of profilin-1. The Journal of Biological Chemistry. 290: 9075-86. PMID 25681442 DOI: 10.1074/Jbc.M114.619874 |
0.586 |
|
| 2014 |
Wolf DM, Lenburg ME, Yau C, Boudreau A, van 't Veer LJ. Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity. Plos One. 9: e88309. PMID 24516633 DOI: 10.1371/Journal.Pone.0088309 |
0.44 |
|
| 2014 |
Coppé JF, Mori M, Lee E, Pan B, Boudreau A, Chen Z, Veer Lv'. Abstract 5309: Phospho-reactome profiling reveals the heterogenic, targetable kinase signature of breast cancer Cancer Research. 74: 5309-5309. DOI: 10.1158/1538-7445.Am2014-5309 |
0.416 |
|
| 2013 |
Boudreau A, Tanner K, Wang D, Geyer FC, Reis-Filho JS, Bissell MJ. 14-3-3σ stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion. Proceedings of the National Academy of Sciences of the United States of America. 110: E3937-44. PMID 24067649 DOI: 10.1073/Pnas.1315022110 |
0.663 |
|
| 2013 |
Mori M, Chen Z, Boudreau A, Veer Lv, Coppe J. Kinase-sensing system to identify the oncogenic phospho-fingerprint of breast cancer. Journal of Clinical Oncology. 31: 23-23. DOI: 10.1200/Jco.2013.31.26_Suppl.23 |
0.334 |
|
| 2013 |
Wolf DM, Yau C, Boudreau A, Esserman L, Veer LV‘, Lenburg M. Abstract 5221: Co-expression modules as hallmarks of breast cancer survival and response. Cancer Research. 73: 5221-5221. DOI: 10.1158/1538-7445.Am2013-5221 |
0.435 |
|
| 2013 |
Coppé J, Chen Z, Mori M, Boudreau A, Veer Lv'. Abstract P4-05-02: Phospho-reactome measurements reveal heterogenic kinase signatures Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P4-05-02 |
0.376 |
|
| 2013 |
Wolf D, Daemen A, Yau C, Davis S, Boudreau A, Swigart L, Investigators IT, Esserman L, Veer Lv'. Abstract P1-08-01: MammaPrint ultra-high risk score is associated with response to neoadjuvant chemotherapy in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P1-08-01 |
0.317 |
|
| 2012 |
Di Modugno F, Iapicca P, Boudreau A, Mottolese M, Terrenato I, Perracchio L, Carstens RP, Santoni A, Bissell MJ, Nisticò P. Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors. Proceedings of the National Academy of Sciences of the United States of America. 109: 19280-5. PMID 23129656 DOI: 10.1073/Pnas.1214394109 |
0.606 |
|
| 2012 |
Boudreau A, van't Veer LJ, Bissell MJ. An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity. Cell Adhesion & Migration. 6: 236-48. PMID 22863741 DOI: 10.4161/Cam.20880 |
0.596 |
|
| 2012 |
Boudreau A, Elias S, Yau C, Wolf D, Veer Lv. Abstract P4-09-02: A robust signature of long-term clinical outcome in breast cancer Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P4-09-02 |
0.305 |
|
| 2011 |
Wolf D, Lenburg M, Yau C, Boudreau A, Esserman L, Hylton N, Veer LV'. Abstract LB-311: Combinatorial logic over breast cancer control modules predicts survival and chemotherapy response of ISPY1 breast cancer patients (CALGB 150007/150012; ACRIN 6657) Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-311 |
0.426 |
|
| 2011 |
Boudreau A, Yau C, Petrillo L, Stemke-Hale K, Mills G, Gray J, Wolf D, Veer Lv‘. P5-01-05: Activating Mutations in PIK3CA or AKT1 in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657). Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P5-01-05 |
0.354 |
|
| 2011 |
Wolf D, Yau C, Benz S, Vaske C, Stuart J, Roy R, Olshen A, Boudreau A, Haussler D, Gray J, Spellman P, Davis S, Hylton N, Veer LV, Esserman L. P1-06-09: Patient-Specific Integrative Pathway Analysis Using PARADIGM Identifies Key Activities in I-SPY 1 Breast Cancer Patients (CALGB 150007/150012; ACRIN 6657). Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-06-09 |
0.41 |
|
| 2010 |
Tanner K, Boudreau A, Bissell MJ, Kumar S. Dissecting regional variations in stress fiber mechanics in living cells with laser nanosurgery. Biophysical Journal. 99: 2775-83. PMID 21044574 DOI: 10.1016/J.Bpj.2010.08.071 |
0.576 |
|
| 2010 |
Boudreau A, Geyer FC, Wang D, Reis-Filho JS, Bissell MJ. Abstract 5132: 14-3-3sigma coordinates breast tumor invasion by regulating cytoskeletal dynamics Cancer Research. 70: 5132-5132. DOI: 10.1158/1538-7445.Am10-5132 |
0.625 |
|
| 2009 |
Chen A, Cuevas I, Kenny PA, Miyake H, Mace K, Ghajar C, Boudreau A, Bissell MJ, Bissell M, Boudreau N. Endothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity. Cancer Research. 69: 6721-9. PMID 19654314 DOI: 10.1158/0008-5472.Can-08-4069 |
0.632 |
|
| 2009 |
Xu R, Boudreau A, Bissell MJ. Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices. Cancer Metastasis Reviews. 28: 167-76. PMID 19160017 DOI: 10.1007/S10555-008-9178-Z |
0.505 |
|
| 2007 |
Ro HS, Zhang L, Majdalawieh A, Kim SW, Wu X, Lyons PJ, Webber C, Ma H, Reidy SP, Boudreau A, Miller JR, Mitchell P, McLeod RS. Adipocyte enhancer-binding protein 1 modulates adiposity and energy homeostasis. Obesity (Silver Spring, Md.). 15: 288-302. PMID 17299101 DOI: 10.1038/Oby.2007.569 |
0.314 |
|
| Show low-probability matches. |